This website uses cookies to enhance the user experience.
||
MJ

Morgan Johnsen1966

Shareholdings
1
11
Norway Business roles
16

Roles

Management

NameRoleTotal operating incomeTotal equityShares
U
UMBILICUS EIENDOM AS
Managing Director/CEO
5,240,465
7,526,653
100 %
indirectly
H
HILLSVEI 29 AS
Managing Director/CEO
-
1,496,392
50 %
indirectly

Boards

NameRoleTotal operating incomeTotal equityShares
D
DYREKLINIKKEN I BAMBLE AS
Chairman
10,136,558
-
100 %
indirectly
K
KVIKK UTLEIE AS
Chairman
731,880
341,185
100 %
indirectly
S
SETREVEGEN 30 AS
Chairman
152,240
29,812
100 %
indirectly
L
LIMBUS HOLDING AS
Chairman
-
23,152,190
100 %
directly
S
STRØMTANGVEGEN 20 AS
Chairman
1,591,466
1,006,308
100 %
indirectly
A
APOTEKERGAARDEN AS
Chairman
95,400
1,000,002
100 %
indirectly
S
STRØMTANGVEGEN 22 AS
Chairman
146,000
29,792
100 %
indirectly
U
UMBILICUS EIENDOM AS
Chairman
5,240,465
7,526,653
100 %
indirectly
S
SIGNALVEIEN 8 AS
Chairman
86,000
591,822
100 %
indirectly
O
ODA SOFIES ISBAR AS
Chairman
1,398,121
114,893
91 %
indirectly
A
ALBUS EIENDOM AS
Chairman
250,605
-45,780
52 %
indirectly
H
HILLSVEI 29 AS
Board Member
-
1,496,392
50 %
indirectly
Holder
-
-
-
T
TELEMARK-SVINGEN AS
Chairman
18,460,175
3,400,666
-
Last update: Jul 30, 2026

Shares owned by Morgan Johnsen

NameShare classTotal operating incomeTotal equityShare
L
LIMBUS HOLDING AS
Ordinære aksjer
0
23,152,190
100 %
directly
D
DYREKLINIKKEN I BAMBLE AS
10,136,558
0
100 %
indirectly
K
KVIKK UTLEIE AS
731,880
341,185
100 %
indirectly
S
SETREVEGEN 30 AS
152,240
29,812
100 %
indirectly
S
STRØMTANGVEGEN 20 AS
1,591,466
1,006,308
100 %
indirectly
S
SIGNALVEIEN 8 AS
86,000
591,822
100 %
indirectly
A
APOTEKERGAARDEN AS
95,400
1,000,002
100 %
indirectly
S
STRØMTANGVEGEN 22 AS
146,000
29,792
100 %
indirectly
U
UMBILICUS EIENDOM AS
5,240,465
7,526,653
100 %
indirectly
O
ODA SOFIES ISBAR AS
1,398,121
114,893
91 %
indirectly
A
ALBUS EIENDOM AS
250,605
-45,780
52 %
indirectly
H
HILLSVEI 29 AS
0
1,496,392
50 %
indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025